Results
21
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
21 companies
Torrent Pharmaceuticals
Market Cap: ₹1.2t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,662.95
7D
1.2%
1Y
9.3%
WuXi XDC Cayman
Market Cap: HK$70.0b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.65
7D
-6.9%
1Y
213.0%
Gan & Lee Pharmaceuticals
Market Cap: CN¥40.7b
A biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China.
603087
CN¥67.92
7D
7.7%
1Y
62.3%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥40.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥90.32
7D
0.8%
1Y
88.1%
Laurus Labs
Market Cap: ₹477.2b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹876.05
7D
1.5%
1Y
97.2%
Xiamen Amoytop Biotech
Market Cap: CN¥35.6b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥85.86
7D
-1.4%
1Y
81.0%
Ipca Laboratories
Market Cap: ₹351.0b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.
IPCALAB
₹1,370.40
7D
0.4%
1Y
-2.6%
Emcure Pharmaceuticals
Market Cap: ₹278.6b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,504.50
7D
3.5%
1Y
10.3%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹270.5b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,728.00
7D
0.7%
1Y
-10.2%
Sai Life Sciences
Market Cap: ₹190.2b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹911.15
7D
0.9%
1Y
n/a
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥14.5b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥46.88
7D
1.9%
1Y
5.7%
Acutaas Chemicals
Market Cap: ₹114.3b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹1,398.90
7D
6.2%
1Y
112.3%
Aether Industries
Market Cap: ₹101.5b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹768.20
7D
2.2%
1Y
-14.6%
Jeena Sikho Lifecare
Market Cap: ₹85.3b
Trades in ayurvedic medicines in India.
JSLL
₹724.40
7D
29.2%
1Y
163.2%
ChengDu ShengNuo BiotecLtd
Market Cap: CN¥7.0b
Engages in the research and development, production, sale, and export of peptide drugs.
688117
CN¥45.59
7D
11.2%
1Y
148.4%
Suzhou Highfine Biotech
Market Cap: CN¥6.3b
Manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China.
301393
CN¥58.19
7D
-0.7%
1Y
58.7%
Shilpa Medicare
Market Cap: ₹75.3b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.
530549
₹857.25
7D
-5.5%
1Y
23.4%
Supriya Lifescience
Market Cap: ₹54.5b
Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
SUPRIYA
₹681.40
7D
3.9%
1Y
22.9%
Aarti Drugs
Market Cap: ₹45.1b
Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
524348
₹477.90
7D
-2.1%
1Y
-10.5%
Essex Bio-Technology
Market Cap: HK$3.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.72
7D
5.3%
1Y
131.6%
JBM (Healthcare)
Market Cap: HK$2.4b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.07
7D
7.0%
1Y
248.9%